Laporan Laba Rugi (TTM)
Laporan Laba Rugi Scinai Immunotherapeutics Ltd. - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 1 | 1 | 1 |
| Change (%) | 59.15 | 45.58 | 58.74 | 9.81 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 0 | 1 | 1 | 2 | 3 |
| Change (%) | 93.08 | 43.12 | 82.51 | 25.38 | |
| % of Revenue | 157.75 | 191.37 | 188.15 | 216.32 | 246.99 |
| Gross Operating Profit | -0 | -0 | -1 | -1 | -2 |
| Change (%) | 151.83 | 40.44 | 109.48 | 38.77 | |
| % of Revenue | -57.75 | -91.37 | -88.15 | -116.32 | -146.99 |
| SG&A | 3 | 3 | 3 | 3 | 3 |
| Change (%) | -6.42 | -15.01 | 5.70 | 4.08 | |
| % of Revenue | 1,118.31 | 657.52 | 383.89 | 255.62 | 242.28 |
| R&D | 5 | 5 | 6 | 5 | 4 |
| Change (%) | 6.00 | 14.72 | -17.16 | -13.13 | |
| % of Revenue | 1,601.76 | 1,066.81 | 840.73 | 438.73 | 347.08 |
| OpEx | 8 | 9 | 9 | 10 | 10 |
| Change (%) | 5.95 | 7.47 | 3.66 | -0.45 | |
| % of Revenue | 2,874.65 | 1,913.72 | 1,412.77 | 922.55 | 836.36 |
| Operating Income | -8 | -8 | -9 | -9 | -8 |
| Change (%) | 4.04 | 5.37 | -0.54 | -1.69 | |
| % of Revenue | -2,774.65 | -1,813.72 | -1,312.77 | -822.55 | -736.36 |
| Interest Expense | -5 | -1 | -1 | -1 | |
| Change (%) | -71.42 | -3.20 | -7.95 | ||
| % of Revenue | -1,100.66 | -216.11 | -131.79 | -110.46 | |
| Net Income | -4 | 5 | 5 | 5 | 5 |
| Change (%) | -226.78 | 2.13 | 1.92 | 5.22 | |
| % of Revenue | -1,304.23 | 1,038.94 | 728.88 | 467.98 | 448.39 |
Source: Capital IQ
